Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy have?
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy has 2,958 citations in the OpenAlex counts ScholarIQ stores.
When was Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy published?
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy has 2006 year in the ScholarIQ index.
What is the open-access status of Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy?
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy has closed oa status in the ScholarIQ index.
What is the DOI of Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy?
The DOI for Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy is on the source record.
What is the PMID of Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy?
The PMID for Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy is on the source record.
What is the OpenAlex record for Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy?
The OpenAlex for Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy is on the source record.